[Treatment of hepatitis C. Paris 27-28 February 2002].
D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D016174:Hepacivirus / Q000276:immunology; D018937:Hepatitis C Antibodies / Q000097:blood; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D010297:Paris; D017410:Practice Guidelines as Topic; D012254:Ribavirin / Q000627:therapeutic use; D000637:Transaminases / Q000097:blood; D016896:Treatment Outcome
D000998:Antiviral Agents; D018937:Hepatitis C Antibodies; D012254:Ribavirin; D007372:Interferons; D000637:Transaminases